Imago BioSciences Inventory Surges. It truly is Getting Acquired by Merck.

Merck

announced Monday it would get biopharmaceutical firm

Imago BioSciences

in a offer valued at $1.35 billion.

Prescription drugs giant

Merck

(ticker: MRK) will shell out $36 in income for every share for Imago (IMG), which is about double Imago’s closing rate of $17.40 a share on Friday.

Merck

announced Monday it would get biopharmaceutical firm

Imago BioSciences

in a offer valued at $1.35 billion.

Prescription drugs giant

Merck

(ticker: MRK) will shell out $36 in income for every share for Imago (IMG), which is about double Imago’s closing rate of $17.40 a share on Friday.